We are live on ! Find out more
ALNA

Allena Pharmaceuticals
ALNA

Delisted

ALNA was delisted on the 7th of September, 2022.

Back to rankings

46 hedge funds and large institutions have $62.4M invested in Allena Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

6% less funds holding

Funds holding: 49 → 46 (-3)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

46% less capital invested

Capital invested by funds: $116M → $62.4M (-$54M)

47% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 15

Holders
46
Holders Change
-3
Holders Change %
-6.12%
% of All Funds
1%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
11
Increased
8
Reduced
15
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.78M
2
Renaissance Technologies
Renaissance Technologies
New York
+$335K
3
SFM
Sphera Funds Management
Israel
+$328K
4
Goldman Sachs
Goldman Sachs
New York
+$318K
5
PP
Paloma Partners
Connecticut
+$285K

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$3.68M
2
BlackRock
BlackRock
New York
-$2.69M
3
State Street
State Street
Massachusetts
-$1.27M
4
JP Morgan Chase
JP Morgan Chase
New York
-$941K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$292K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$96K -$41.9K -7,667 -24%
Bank of America
27
Bank of America
North Carolina
$67K +$73K +13,353 +436%
WS
28
Wedbush Securities
California
$63K +$84.1K +15,400 New
RJFSA
29
Raymond James Financial Services Advisors
Florida
$52K +$70.2K +12,850 New
Wells Fargo
30
Wells Fargo
California
$48K -$52.2K -9,560 -45%
Barclays
31
Barclays
United Kingdom
$41K +$38K +6,963 +212%
TAM
32
Tiverton Asset Management
Delaware
$18K – – –
Deutsche Bank
33
Deutsche Bank
Germany
$13K -$94.4K -17,277 -83%
Citigroup
34
Citigroup
New York
$13K -$76 -14 -0.4%
Legal & General Group
35
Legal & General Group
United Kingdom
$7K – – –
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$5.53K -$6.1K -1,116 -45%
NA
37
Neuburgh Advisers
California
$4K – – –
FCM
38
Flinton Capital Management
Pennsylvania
$3K – – –
TAM
39
Tyers Asset Management
Texas
$3K – – –
TRCT
40
Tower Research Capital (TRC)
New York
$3K +$4.58K +839 New
GHCM
41
Glen Harbor Capital Management
California
$2K – – –
MAM
42
Meeder Asset Management
Ohio
$2K +$1.34K +246 +127%
CIAS
43
Capital Investment Advisory Services
North Carolina
$2K +$2.73K +500 New
PCP
44
Proficio Capital Partners
Massachusetts
$1K +$1.32K +241 New
State Street
45
State Street
Massachusetts
– -$1.27M -181,520 Closed
Squarepoint
46
Squarepoint
New York
– -$284K -40,400 Closed
Charles Schwab
47
Charles Schwab
California
– -$198K -28,139 Closed
OAM
48
Oxford Asset Management
United Kingdom
– -$151K -21,572 Closed
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
– -$125K -17,743 Closed
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
– -$110K -15,600 Closed
1
2
3

ALNA Hedge Fund Activity: Q2 2019 in Review

46 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q2 2019, worth a combined $62.4M — down 46% from $116M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ALNA and 11 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 8 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.78M. The largest seller was PFM Health Sciences, cutting an estimated $3.68M.

  • 46 institutional investors held Allena Pharmaceuticals (ALNA) as of Q2 2019, down from 49 in Q1 2019.
  • Funds reported $62.4M of Allena Pharmaceuticals stock for Q2 2019, down 46% quarter-over-quarter.
  • 11 funds opened new Allena Pharmaceuticals positions in Q2 2019 and 12 closed out, a net change of -1 holder.
  • The largest Allena Pharmaceuticals buyer in Q2 2019 was Millennium Management, an estimated $1.78M added.
  • The largest Allena Pharmaceuticals seller in Q2 2019 was PFM Health Sciences, an estimated $3.68M sold.

Based on aggregated 13F filings for Q2 2019.